Outsourcing Innovation eBook February 2024
Read the article: A Closer Look at Affinity Ligands
Read the eBook: Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook February 2024
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
Graphene water filter, 3D illustration | Image Credit: © Dr_Microbe - stock.adobe.com; doctor analyzes monoclonal antibodies | Image Credit: © Paulista - stock.adobe.com; Final image by Maria Xelo
Affinity ligands play an exciting role in the ever-growing sphere of downstream processing. In speaking with Pharmaceutical Technology®, Phillip Elliott, PhD, associate director of Process Development, BioCina; Jan Bekker, PhD, director, Business Development, Commercial and Technical Operations, BioCina; and Parviz Shamlou, PhD, senior vice-president of Science & Technology, Abzena illuminate the newest innovations with affinity ligands and provide a deeper understanding of the role affinity ligands play in the future of downstream processing.
Read this article in Pharmaceutical Technology’s Bio/Pharma Outsourcing Innovation eBook.
Read the article: A Closer Look at Affinity Ligands
Read the eBook: Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook February 2024
Daria Husni is assistant editor to Pharmaceutical Technology® and Pharmaceutical Technology Europe®.
Pharmaceutical Technology/Pharmaceutical Technology Europe Outsourcing Innovation eBook
Issue 2
February 2024
Pages: 16-21
When referring to this article, please cite it as Husni, D. A Closer Look at Affinity Ligands. Pharmaceutical Technology, Bio/Pharma Outsourcing Innovation eBook. February 2024.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.